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Toxicokinetics of Bone Lead
by Michael B. Rabinowitz*
This article discusses bone as a source oflead to the rest of the body and as a record of past lead
exposure. Bone lead levels generally increase with age at rates dependent on the skeletal site and
lead exposure. After occupational exposure, the slow decline inblood lead, a 5- to 19-year half-life,
reflects the long skeletal half-life. Repeated measurements ofbone lead demonstrate the slow elim-
ination ofleadfrombone. Stable isotoperatioshaverevealedmanydetails ofskeletaluptakeand sub-
sequent release. The bulk turnover rates for compact bone are about 2% per year and 8% for spine.
Turnover activity varies with age and health. Even though lead approximates calcium, radium,
strontium, barium, fluorine, and other bone seekers, the rates for each are different. A simple, two-
pool (bone and blood) kinetic model is presented with proposed numerical values for the changes in
blood lead levels that occur with changes in turnover rates.
Two approaches are offered to further quantify lead turnover. One involves a study of subjects
with known past exposure. Changes in the ratio ofblood lead to bone lead with time would reflect
the course ofbone leadavailability. Also, stable isotopesandsubjects who move from one geographi-
cal area to another offer opportunities. Sequential isotope measurements would indicate how much
ofthe lead in blood is from current exposure or bone stores, distinct from changes in absorption or
excretion.
Introduction
Toxicokinetics can be defined as the measuring and
modeling ofthe movement oftoxic substances, such as
lead, within the body. Toxicokinetics should be distin-
guished from analytical chemistry, which addresses
questions of how much lead is in a sample, such as
bone. Toxicokinetics would try to provide answers to
such questions as how long the lead has been in the
bone, where the lead came from, and when and to
where might it be going. The effects of lead are not
addressed.
In this discussion of the movement of lead through
the body and its chemical dynamics, I shall focus on
bone andaskthefollowingquestions: a)What are some
general characteristics oflead in bone? b) To what ex-
tent can the bone act as a source of lead to the rest of
the body? c) How can bone lead levels be used to moni-
tor past exposure? d) What are some immediate re-
search needs or opportunities related to the kinetics of
bone lead?The following is a simplified account oflead
kinetics and somerough numerical estimates ofthe re-
lationships between bone lead and blood lead levels.
What Are Some General
Characteristics of Lead in Bone?
Fromtheavailable surveys ofautopsy andbiopsy ma-
terial some general trends are apparent (1). Bone lead
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levels increasewithage atratesdependentonthe skel-
etal site and lead exposure (2). Bilateral symmetry is
present. Anothersetofstudieshasinvolvedmeasuring
the stable isotope abundance ratios with a mass spec-
trometer in biopsied bone and comparing it to blood
lead isotope ratios. Some studieshave made use ofgeo-
graphical variations in lead ores to examine the up-
take and release of lead by the skeleton (3). Manton
lived in South Africa, and his skeletal lead acquired
the isotopic composition ofthat environment (3). After
moving to Texas and being exposed to a new isotopic
ratio, his blood did not immediately come to resemble
his new exposure. Similar patterns were reported for
his family members, including increased mobilization
of skeletal lead during pregnancy. By following three
adults over9years, includingabonebiopsy, itwaspos-
sible for Manton to describe the general long-term dy-
namics oflead in the body (3).
Other stable isotope studies have involved feeding
five adult volunteers enriched, stable isotope tracer.
This was done in a special metabolic balance ward by
placingthemenonconstant low-leaddiets,whichwere
supplemented with enough lead to achieve their pre-
study intake (4). Afterdiscontinuingthe tracer intake,
bone biopsies and long-term follow-up of blood lead
levels revealed the skeletal uptake and subsequent re-
lease ofthe tracer.
Months after a lead-exposed person discontinues ex-
cessive intake and their blood lead has had an oppor-
tunity todecline, the subsequent decrease is very slow.
Amont65workers,thehalf-livesofleadinboneranged
from 5 to 19 years (5). The blood lead levels stay ele-M. B. RABINOWITZ
vated in response to lead leaving the skeleton. By ex-
aminingthe rates ofdecline inthe leadlevels, the sup-
porting lead pool may be estimated. This was also de-
monstrated by the correlation ofblood lead and bone
lead among 27 active and 9 retired lead workers.
Among the active workers, the nonparameteric r was
0.44, but among the retired workers, whose blood lead
issuppliedpredominantlybytheirbone,thebone lead-
bloodleadcorrelation was 0.93 (6). Also, repeated mea-
surements of finger bone lead in 14 retired workers
showed a very slow elimination, with about a 7-year
half-life (7).
Experiments with short-lived radioactive lead have
demonstrated the affinity ofbone for lead. For exam-
ple, 3 weeks after lead dosage, 20% ofthe lead was in
the urine, and 20% wasboundtothe skeleton(8). Bone
uptake ofradio-calcium was more rapid than lead up-
take, inpartbecause redbloodcellshave a stronger af-
finity for lead than for calcium.
A simplekinetic model oflead inthebodyconsists of
only twopools(Fig. 1). Lead inthebody is either inthe
blood (or in equilibrium with it) or in the skeleton,
where it is bound and less able to exchange. Within
each pool, rapid andcomplete equilibrium is assumed.
It is possible to obtain the sizes and exchange rates of
these pools from the blood tracer data. Estimated val-
ues are shown in Table 1.
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FIGURE 1. Simplified two-pool kinetic model. It is assumed that all
ofthe lead inthe body is one oftwopools. The bloodpool contains
lead in blood and in tissues equilibrating with blood, including
many potential target organs such as the brain and kidneys.
Table 1. Approximate values for the two-pool
kinetic adult model.
Parameter Blood pool Bone pool
Mean life 1 month 10-30 years
Lead concentration 10 Itg/dL 0.1 ppm 5 ppm
Pool mass 10 kg blood + marrow, liver, 5 kg bone
kidney, etc. 4 cortical
1 trabecular
Lead mass 0.5-1 mg 25-750 mg
These models take the form of coupled differential
equations whose solutions are the sum oftwoexponen-
tial terms. Other models involving additional pools
havebeenproposedthatdividethebone intolabile and
deeppools(9). Also,the softtissuehasbeenmade asep-
arate pool apart from blood in other models (10). Mod-
elswith varyingratesofexposure anduptakefortooth
and bone lead have been proposed (11).
Allthe leadinbone is not inone well-mixedpool(12).
Forexample, somebone lead, as assessedwith softL X-
raysofthetibia, is available to ethylene diamine tetra-
acetic acid (EDTA) chelation (13). Similarly, compari-
sons of EDTA chelation and iliac biopsies show the
availabilityofbonelead(14). Thus, abetterapproxima-
tionmightinvolve aseries ofinterconnectedpools(Fig.
2). Theinabilityofchelationtoremove appreciablepro-
portions ofbone lead argues that some is buried and
unavailable for exchange. With the passage of years
and the turnover and remodeling of bone by osteon
activity, buried lead may become available again.
A recent report involving laser microbeam mass
analysis and electron microprobe X-ray analysis ofse-
quential needle biopsies of a poisoned woman subject
has demonstrated the localized distribution oflead in
bone (15). The bone marrow cell nuclei showed very
highconcentrations. Evenafterchelationconsiderable
lead remains in the organic portion.
To fully understand bone release rates oflead, some
knowledge of bone turnover rates would be useful.
Eventhoughleadapproximatescalcium,radium, stron-
tium, fluorine, and other bone-seeking elements, the
actualnumericalratesofbonereleaseforeachelement
are somewhat different (16). In the case of fluorine,
which replaces the OH- ofthe apatite, bone stores can
be rapidly exchanged. The turnover rate of the bone
mineral can be a rate-limiting step for elements that
are very tightly boundto apatite. This explains the in-
ability ofchelating agents to lower bone pools ofbone-
seeking elements and their limited ability ifthe chel-
ant is administered shortly after exposure (17). Once
the lead has penetrated the crystal surface, itbecomes
firmly buried and must await osteoclastic turnover,
leading to the multipool bone model described earlier
in Figure 2.
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FIGURE 2. Multiple bone pool kinetic model. Not all of the lead in
bone is equally exchangeable with blood. Pools may be envi-
sioned with varying degrees of accessibility.
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Mathematical attempts to describe these series of
connectedpools are not simple (18). These longer term
aspects ofblood lead in response to uptake andrelease
ofbone leadarewelldescribedby apowerfunction. For
example, aseriesofexponentialterms oraBesselfunc-
tion can describe the residence times of lead in bone
(19). Itistemptingtorelate slowandslowerbonepools,
correspondingtodifferenttermsinthepowerfunction,
with specific gross anatomical locations such as long
bone or trabecular or ivory bone. I suspect any cubic
centimeter ofskeleton will contain some ofeach kind
ofbone in varying amounts. Deep and very deep bone
poolsmayalsospatially coexistmoreclosely, separated
by their locations on a mineral crystal, superficial or
internal.
The actual turnover rates of compact human bone
can be estimated by the osteon formation rate, which
canbeobservedmicroscopically indatedbone(20). The
osteon count is proportional to age. Another histologi-
cal methodinvolves measuringthefractionofcompact
bone that is lamellar or contains neither osteon nor
non-Haversian vascular canals. Both approaches give
turnoverratesforbonesofabout 2% peryearforthe fe-
mur, tibia, and fibula. Calculated turnover rates, em-
ployingosteon counts, forspecificboneshavebeentab-
ulatedrangingfromthetibiaandskull,which average
lessthan 2%, to 8.3% for the spine. There is also varia-
tion in turnover rates by age. During the first year
rates are very high, 85%, but fall near 7% in the twen-
ties and 2% in the thirties. Rates apparently increase
again to over 4% after 60 years.
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FIGURE 3. Plot of the amount of lead in the bone pool against the
turnover rate of the bone pool. Each line represents points of
equal lead release by bone. For example, if the bone turnover
half-life is 35years andthepersonhas200mgofbonelead(point
A), then each day the bone releases 11 itg oflead into the blood.
The difference in blood lead levels associated with that release
is about 3 jig/dL. However, for the same person with the same
size bone leadpool, in the normal course ofaging, bone turnover
rates accelerate to a 15-year half-life, then 25 ig/day would re-
leased by the bone, thereby increasing blood lead by about
7Lg/dL (point B). Point C represents a further acceleration in
bone turnover in response to disease state. Points A', B', and C'
represent a person with a greater body store of lead and sub-
sequently greater changes in blood lead from changes in bone
turnover.
To What Extent Can the Bone Act
As a Source of Lead to the Rest of
the Body?
Rather than review examples of lead poisoning (21)
and ofincreased bloodlead levels that came from bone
lead stores(22), I offerthis somewhat hypothetical and
simplistic approach to quantifying bone as a source.
Consider the simple two-pool model (Fig. 1) ofblood
and bone. What is the relative amount oflead in blood
for agivenamountofleadinbone?Thisdepends onthe
turnover ratesofeachpool. Forexample, the amount of
lead in the bone pool can be plotted against the turn-
over rate ofthe bone pool (Fig. 3). Each line represents
points ofequal leadflux out ofor intothe skeleton. For
example, ifthe bone turnover half-life is 35 years and
the personhas200 mgofbone lead(pointA), theneach
day the bone releases 11 jg oflead into the blood. The
difference inblood lead levels that wouldbe associated
with changes in that amount of daily lead going into
the blood, 11 Ag/day, is only about 3 Ag/dL. However,
withthe same sizebone leadpool, inthe normal course
ofaging, ifthe bone lead turnover rate accelerated to
ahalf-life of15 years, then closerto 25 pg/daywouldbe
coming into the blood from the bone, thereby increas-
ingblood lead by about 7 jg/dL (point B). Should bone
turnover rates increase further, perhaps to a 7-year
half-life, in response to metabolic disturbances or dis-
ease(pointC), thenthismodelwouldpredict 55itg/day
coming from the skeleton, increasing blood leadby 16
iug/dL. Even ifabsorption and excretion rates for lead
are constant, and only the bone lead turn-over rate in-
creases, the blood lead levels can be expected to in-
crease. The change inblood leadlevel fromchanges in
bone turnover rates become more dramatic in cases
typical ofoccupational exposure. Ifbone stores amount
to 450 mg and the bone turnover rate increased from
2% to 4.5 or 10% per year, then blood leads would in-
crease by 9 (16 - 7) or 26 (33 - 7)/zg/dL (points A', B',
and C').
Expressed algebraically, if C is the change in daily
bone lead output (in units ofptg/day) from a change in
bone leadturnoverrates, Rl isthe initial andR2 isthe
second rate (units of 1/day), and S is the skeletal pool
lead mass (Jg), then C = S x (R2 - Ri). After several
months, blood lead levels achieve a new and higher
steady-state value with this change in bone lead out-
put. The change in blood lead, B (jig/dL) associated
with a change in bone flux C, where RB is the blood
pool turnover rate (in units of 1/day), about a month,
and Mis the mass ofthe bloodpool expressed as a vol-
ume, which includestheblood and other tissueswhich
rapidly equilibrate with blood, about 10 L, then B =
C/(M x RB).
Considering bone as a source implies thatblood lead
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might be a better marker ofcurrent bone output than
a single measurement of bone itself. Bone measure-
ments are markers of potential output. This under-
lines the value ofrepeated measures ofavailable bone
lead to ascertain transfer rates.
So far we have considered the skeletal mass to re-
main constant in size but to turnover and exchange
lead. However, the skeletal compartments can also
become larger or smaller. The calcium mineral mass
may grow during development, aging or, for example,
in response to ergocalciferol (23). Changes of 2% in
skeletal density can be resolved with current tech-
niques. More complete models of lead kinetics might
include changes in pool size.
How Can Bone Lead Levels Be Used
As a Monitor of Past Exposure or
Current Risk?
Bone accumulatesleadandprovides amarkerofpast
exposure. Although it would be useful to distinguish
between two extreme types of exposure, a single high
dose or a long-term, lower dose, we are not yet able to
do so. With acute exposure, a high blood lead level is
achieved for a short time. If one of lead's toxic effects
were dose related in a threshold fashion, the lead in
blood would be high enough to damage some target
organ, such asthe brain orkidney. Inthe case ofchron-
ic exposure, elevatedbloodlead levels mightpersistfor
years, with large amounts of lead deposited in bone.
Perhaps some oflead's toxic effects are proportional to
cumulative exposure. Ifthe sametotal quantity oflead
weretakeneach way, acutely orchronically, Iwould ex-
pect a greater bone signal from those chronically ex-
posed, even though their blood lead might not have
achieved as high a peak. So chronic or acute exposure
to lead would be indistinguishable by bone assay but
with markedly different physiological effects.
Lead deposited in bones can become less available
with time. A sampling method that can discriminate
old versus more newly deposited lead would be useful.
Investigations amongleadworkers in Sweden have ad-
dressed this issue of multiple measures of bone lead
(24). Schutz et al. found chelatable lead to correlate
with blood lead (n = 37, r = 0.93) and with trabecular,
vertebral bone lead (n = 23, r = 0.81) (24). However,
chelatable leadcorrelatedpoorlywithfingerbone lead
measured with K X-rays (n = 23, r = - 0.21) (24). This
confirms the existence of an inert, nonchelatable pool
and a more labile pool in bone.
What Are the Most Immediate
Research Needs or Opportunities
Related tothe Kinetics of Bone Lead?
More should be learned about the factors affecting
lead turnover inbone. Lead and calcium are similar, so
changes in calcium metabolism affect lead movement
within the body. Blood lead level increases secondary
to changes in calcium status have been seen in osteo-
porosis, lactation, and aging. However, lead, calcium,
and other alkaline earth elements may have turnover
ratesinbonesufficiently differentfromeachother, and
the ratio of their rates may be sufficiently different
from person to person that measurements oflead kin-
etics would be much more useful than measurements
ofcalciummetabolismalone(25). Under certain condi-
tions lead might be mobilized from bone to a greater
extent than is calcium. In other words, we need more
information about the turnover rates of lead in hu-
mans in their slower (longer than a year) body pools.
How much of the bone lead mass is involved in inert,
slow, or labile metabolicpools? Usingvarious-strength
X-rays and using different anatomical sites, past ex-
posure can be reconstructed.
Towhatextentdoesleadinbonebecome progressive-
ly less available over the passage of years? Consider
the sequence ofa)substantialexposureresultinginthe
accumulation ofbone stores ofleadfollowedby b)years
of much lower exposure with lowering of blood lead,
some bone stores staying elevated, and c) some meta-
bolic mobilization ofbone stores. Does the amount of
mobilized bone lead decrease with the amount oftime
available for deeper burial by bone turnover? Does the
freshness of exposure affect bone availability with a
progressive deeperburial? Alternatively, does the pas-
sage oftime after the cessation ofexposure have no ef-
fect on availability? Is the situation one of awaiting
some event, such as pregnancy orparathyroid disease,
that would trigger increased mobilization?
Perhaps one ofthe following two approaches might
be useful. A registry could be created of subjects who
developed leadpoisoningfrom mobilizedbody stores of
lead and not current exposure. Their bone lead and
bloodleadlevelscouldbetabulatedaccordingtothe in-
terval since cessation of major exposure. From the
changes inthe ratio ofblood leadtobone leadwith age
and with time since exposure, we could determine to
what extent lead becomes progressively more deeply
buried or available with time.
Another more direct method might employ stable
isotope tracer methods to distinguish past versus re-
cently absorbedlead,but itwouldrequire subjectswho
have moved from one area to another. Using an ex-
treme case as an ideal example, leads from Port Pirne,
Australia (206/204 = 16.1) and Barberton, South Afri-
ca (206/204 = 12.5) are very different from typical or
common lead(206/204 = 18-19) or Missouri lead(206/
204 = 20-22). These ratios can be measured to finer
than ± 0.005 with a dedicated, solid source mass spec-
trometer. If a woman grew from birth to maturity at
one such place, then moved and after a delay of a few
years became a mother, sequential lead isotope mea-
surements would indicate how much ofthe lead in her
blood is from current exposure and how much is from
bone stores. This would indicate the extent to which
pregnancy mobilized stored lead as distinct from
changes in absorption or excretion rates.
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